GlassScriptPhysician profile
Nicholas A Benites
NPI 1174882807
$3,605.59
in general payments reported to CMS, 2019-2025
21 companies · $715 in 2025
The $715 reported for 2025 was more than what 78% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,199 · 2022: $353 · 2023: $608 · 2024: $731 · 2025: $715.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,960 · Education: $94.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,960.24 |
| Education | $94.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,463.84 | 2021-2025 | |
| Ucb, INC. | $685.95 | 2023-2025 | Bimzelx, Cimzia |
| Janssen Biotech, INC. | $284.47 | 2021-2025 | Tremfya |
| Sun Pharmaceutical Industries INC. | $189.62 | 2021-2023 | Ilumya |
| Amgen INC. | $164.93 | 2021-2024 | Otezla |
| Genzyme Corporation | $131.83 | 2021-2025 | |
| Novartis Pharmaceuticals Corporation | $116.09 | 2021-2025 | |
| Glaxosmithkline, LLC. | $92.12 | 2021 | |
| Leo Pharma INC. | $85.00 | 2021-2025 | Anzupgo |
| Csl Behring | $60.27 | 2021 | |
| Lilly USA, LLC | $52.61 | 2021-2023 | Taltz |
| Pfizer INC. | $51.38 | 2021-2024 | |
| Incyte Corporation | $43.00 | 2021-2025 | Opzelura |
| Galderma Laboratories, L.P. | $39.08 | 2024 | |
| Allergan, INC. | $37.79 | 2021 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $26.09 | 2024 | Dupixent |
| Arcutis Biotherapeutics, INC. | $22.10 | 2024 | Zoryve |
| Paratek Pharmaceuticals, INC. | $16.56 | 2021 | |
| Journey Medical Corporation | $15.40 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $15.23 | 2025 | Sotyktu |
| Astrazeneca Pharmaceuticals LP | $12.23 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nicholas Benites listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.